Seattle, Washington — September 30, 2025 — Leads & Copy — Parse Biosciences has announced that Single Cell Discoveries, based in the Netherlands, is joining its Certified Service Provider (CSP) Program. As a certified provider, Single Cell Discoveries will broaden access to Parse’s single-cell technology, combining it with a dedicated single-cell science team to assist researchers in Europe and worldwide.
The CSP Program, launched in 2024, connects researchers with vetted partners for outsourcing single-cell projects. It maintains high standards for data quality, scalability, and service to help labs accelerate discovery.
According to Mauro Muraro, PhD, co-founder and CEO of Single Cell Discoveries, joining Parse’s Certified Service Provider program reflects their commitment to single-cell science leadership. He added that partnering with Parse’s scalable technology allows them to deliver high-quality results for both focused pilots and atlas-scale studies.
Alex Rosenberg, CEO and co-founder of Parse Biosciences, stated that expanding their CSP network ensures researchers have reliable access to single-cell services. He noted that Single Cell Discoveries’ focus on single-cell research, complemented by Parse’s scalability and precision, makes them a trusted partner for scientists.
Parse Biosciences is a life sciences company focused on advancing human health and scientific research through single-cell sequencing solutions. Its product portfolio includes Evercode Whole Transcriptome, Evercode TCR, Evercode BCR, CRISPR Detect, Gene Select, and Trailmaker for data analysis. Single Cell Discoveries, based in Utrecht, specializes in single-cell sequencing, spatial transcriptomics, and multiomic applications, partnering with biopharmaceutical organizations and academic institutions.
Source: Parse Biosciences
